Research - Munich, Bavaria, Germany
We are a planned spin-out from the Technical University of Munich, specialising in the clinical and commercial development of a proprietary oncolytic virus platform for cancer immunotherapy.
reCAPTCHA
Apache
WordPress.org
Google Font API
Mobile Friendly
Bootstrap Framework